Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

1992 • 3,247 citations

A Clinician's Guide to Cost-Effectiveness Analysis

1990 • 729 citations

Clinical Economics

1989 • 701 citations

Decision Analysis

1987 • 473 citations

Symptom Status and Quality of Life Following Prostatectomy

1988 • 442 citations

A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

1992 • 314 citations

Epidemiology and Natural History of Benign Prostatic Hyperplasia

1990 • 298 citations

Watchful Waiting vs Immediate Transurethral Resection for Symptomatic Prostatism

1988 • 273 citations

Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies

1991 • 242 citations

Finasteride

1994 • 229 citations

The clinical development of a 5α-reductase inhibitor, finasteride

1990 • 221 citations

An Assessment of Prostatectomy for Benign Urinary Tract Obstruction

1988 • 193 citations

Natural history of benign prostatic hypertrophy and acute urinary retention

1976 • 143 citations

Finasteride

1993 • 99 citations

Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia

1990 • 85 citations

Safety assessment of terazosin in thetreatment of patients with symptomatic benign prostatic hyperplasia: A combined analysis

1994 • 62 citations

Maintenance of Clinical Efficacy With Finasteride Therapy for 24 Months in Patients With Benign Prostatic Hyperplasia

1994 • 55 citations

Terazosin in the Treatment of Benign Prostatic Hyperplasia: A Multicentre, Placebo‐Controlled Trial

1992 • 51 citations

Clinical experience: symptomatic management of BPH with terazosin.

1988 • 47 citations

The costs of prostatectomy for benign prostatic hyperplasia

1993 • 28 citations

Finasteride for the Treatment and Control of Benign Prostatic Hyperplasia: Summary of Phase III Controlled Studies

1994 • 23 citations

Effect of terazosin on urine storage and voiding in the aging male with prostatism

1994 • 23 citations

The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.

1989 • 20 citations

Mortality and reoperation followingprostatectomy: Outcomes in a medicare population

1991 • 19 citations

Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.

1993 • 11 citations

Benign prostatic hyperplasia: drug and nondrug therapies.

1992 • 10 citations

Benign Prostatic Hyperplasia: Intervene or Wait?

1992 • 6 citations

Management of benign prostatic hyperplasia.

1994 • 3 citations

Deleted Work

1955 • 0 citations